Market Research Report
ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026
|Published by||Inkwood Research||Product code||618284|
|Published||Content info||92 Pages
Delivery time: 2-3 business days
|ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026|
|Published: March 26, 2018||Content info: 92 Pages||
Over the projected years of 2018-2026, the Asia Pacific cardiovascular ultrasound system market is forecasted to showcase the highest CAGR of 6.24%. Factors like growing incidences of cardiovascular diseases and growing demand for minimally invasive procedures are driving the market growth in this region.
The Asia-Pacific cardiovascular ultrasound system market is segmented on the basis of technologies, test-type and display device. Presently, the 2D ultrasound technology dominates this region while stress echocardiogram and black and white display captured a significant share of test-type and display segment in 2017. The China vascular ultrasound market is expected to showcase a significant CAGR rise over the forecast period. However, the high cost of surgeries and unfavourable reimbursement policies could restrain the market growth considerably.
Ge Healthcare Inc, Hitachi Medical Corporation, Samsung Electronics Co. Ltd, Toshiba Medical Systems Corporation, Abbott Vascular Inc, Fujifilm Holdings Corporation, Philips Healthcare, Atricure Inc, Esaote S.P.A, Stryker Corporation and Mindray Medical International Limited are eminent players operating in this market.